FDA Inspection
EversightEversight – FDA Inspection, Feb 19, 2019
Record Details
This FDA Inspection record concerns Eversight, with an inspection on February 19, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f5b96dfd-2077-4230-ba3f-e2e08e875fe4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1079760
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.50(a)Responsible person to determine, document
- 21 CFR 1271.55(a)(2)Eligibility statement--basis of determination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eversight
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 22, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 2, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 9, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 4, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Eversight
- FDA Inspection 1178408 - 2022-08-18
- FDA Inspection 986660 - 2016-09-22
- FDA Inspection 872698 - 2014-04-02
- FDA Inspection 793821 - 2012-08-09
- FDA Inspection 632949 - 2009-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.